[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Standard Biotools Inc (LAB)

Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 382,170
  • Shares Outstanding, K 390,368
  • Annual Sales, $ 85,330 K
  • Annual Income, $ -74,900 K
  • EBIT $ -110 M
  • EBITDA $ -102 M
  • 60-Month Beta 1.32
  • Price/Sales 4.28
  • Price/Cash Flow N/A
  • Price/Book 0.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.12
  • Most Recent Earnings $0.06 on 02/24/26
  • Next Earnings Date 05/05/26 [AMC]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Options Overview Details

View History
  • Implied Volatility 160.12% (-88.39%)
  • Historical Volatility 53.01%
  • IV Percentile 32%
  • IV Rank 19.59%
  • IV High 735.30% on 03/16/26
  • IV Low 20.04% on 09/04/25
  • Expected Move (DTE 9) 0.2210 (22.33%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 8
  • Volume Avg (30-Day) 238
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 5,103
  • Open Int (30-Day) 3,055
  • Expected Range 0.7687 to 1.2107

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.03
  • Number of Estimates 1
  • High Estimate $-0.03
  • Low Estimate $-0.03
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8701 +11.27%
on 04/14/26
1.0399 -6.89%
on 04/21/26
+0.0782 (+8.79%)
since 04/06/26
3-Month
0.8701 +11.27%
on 04/14/26
1.2800 -24.36%
on 02/10/26
-0.2918 (-23.16%)
since 02/06/26
52-Week
0.8701 +11.27%
on 04/14/26
1.7200 -43.71%
on 12/22/25
-0.0918 (-8.66%)
since 05/06/25

Most Recent Stories

More News
Standard BioTools: Q1 Earnings Snapshot

Standard BioTools: Q1 Earnings Snapshot

LAB : 0.9759 (-0.32%)
Standard BioTools Reports First Quarter 2026 Financial Results

BOSTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended March 31, 2026....

LAB : 0.9759 (-0.32%)
Can Standard BioTools Prove Cost Cuts Translate to Survival Without Revenue Momentum?

Barchart Research What to Expect from LAB Earnings LAB Generated May 4, 2026 Current Price $0.9350 EPS Estimate $$-0.04 Consensus Rating Moderate Buy Average Move 8.90% Can Standard BioTools Prove Cost...

LAB : 0.9759 (-0.32%)
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026

BOSTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its first quarter 2026 financial results on Tuesday, May 5, 2026, after U.S....

LAB : 0.9759 (-0.32%)
Standard BioTools: Q4 Earnings Snapshot

Standard BioTools: Q4 Earnings Snapshot

LAB : 0.9759 (-0.32%)
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results

BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter and fiscal year...

LAB : 0.9759 (-0.32%)
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24,...

LAB : 0.9759 (-0.32%)
Standard BioTools Completes Sale of SomaLogic to Illumina

Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet...

ILMN : 141.92 (+2.05%)
LAB : 0.9759 (-0.32%)
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced preliminary and unaudited revenue results for the fourth...

LAB : 0.9759 (-0.32%)
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry

Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility

LAB : 0.9759 (-0.32%)

Business Summary

Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm...

See More

Key Turning Points

3rd Resistance Point 1.0513
2nd Resistance Point 1.0157
1st Resistance Point 0.9973
Last Price 0.9759
1st Support Level 0.9433
2nd Support Level 0.9077
3rd Support Level 0.8893

See More

52-Week High 1.7200
Fibonacci 61.8% 1.3953
Fibonacci 50% 1.2951
Fibonacci 38.2% 1.1948
Last Price 0.9759
52-Week Low 0.8701

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.